Mannkind (MNKD) Cash from Investing Activities Growth (5y) (2015 - 2026)
Mannkind (MNKD) Cash from Investing Activities Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Mannkind |
1.21 Bn |
1.08 Bn |
82.66 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
21.02% |
| Dec 31, 2025 |
-130.57% |
| Sep 30, 2025 |
-474.62% |
| Jun 30, 2025 |
112.87% |
| Mar 31, 2025 |
-21.38% |
| Dec 31, 2024 |
199.44% |
| Sep 30, 2024 |
-66.95% |
| Jun 30, 2024 |
-109.45% |
| Mar 31, 2024 |
-14.11% |
| Dec 31, 2023 |
-100.44% |
| Jun 30, 2022 |
142.72% |
| Mar 31, 2022 |
-34.32% |
| Mar 31, 2021 |
-94.56% |
| Dec 31, 2020 |
-70.38% |
| Sep 30, 2020 |
67.79% |
| Jun 30, 2020 |
49.43% |
| Mar 31, 2020 |
46.39% |
| Dec 31, 2019 |
57.29% |
| Sep 30, 2019 |
80.82% |
| Jun 30, 2019 |
30.19% |
